Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Dyrehospitalet Heden ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.5% 1.5% 1.4% 0.9% 1.0% 0.8% 10.6% 10.6%   Credit score (0-100)   78 77 78 87 85 90 23 23   Credit rating   A A A A A AA BB BB   Credit limit (kDKK)   13.5 13.0 33.8 433.2 285.5 1,303.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,986 7,472 9,487 12,427 9,903 20,599 0.0 0.0   EBITDA   1,514 1,441 2,089 2,773 2,259 5,358 0.0 0.0   EBIT   1,350 1,174 1,285 2,153 1,829 4,529 0.0 0.0   Pre-tax profit (PTP)   1,331.0 1,146.3 1,271.7 2,151.1 1,846.1 4,433.7 0.0 0.0   Net earnings   1,038.1 884.6 990.6 1,683.1 1,443.7 3,455.0 0.0 0.0   Pre-tax profit without non-rec. items   1,331 1,146 1,272 2,151 1,846 4,434 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,021 4,024 4,292 4,299 4,335 4,329 0.0 0.0   Shareholders equity total   1,313 1,546 1,736 2,519 2,363 5,818 5,566 5,566   Interest-bearing liabilities   1,557 1,485 1,415 1,344 1,331 1,843 0.0 0.0   Balance sheet total (assets)   4,184 5,783 6,645 7,437 7,422 14,268 5,566 5,566   Net Debt   34.7 1,290 834 454 75.1 -6,295 -5,566 -5,566     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,986 7,472 9,487 12,427 9,903 20,599 0.0 0.0   Gross profit growth   -1.6% 87.5% 27.0% 31.0% -20.3% 108.0% -100.0% 0.0%   Employees   7 14 16 20 24 25 0 0   Employee growth %   0.0% 100.0% 14.3% 25.0% 20.0% 4.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,184 5,783 6,645 7,437 7,422 14,268 5,566 5,566   Balance sheet change%   6.6% 38.2% 14.9% 11.9% -0.2% 92.2% -61.0% 0.0%   Added value   1,514.2 1,441.2 2,089.2 2,773.0 2,449.6 5,357.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -322 1,735 -536 -613 -394 -834 -4,329 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   33.9% 15.7% 13.5% 17.3% 18.5% 22.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   33.3% 23.8% 20.9% 30.9% 25.0% 41.8% 0.0% 0.0%   ROI %   48.2% 37.8% 38.9% 58.4% 43.4% 69.5% 0.0% 0.0%   ROE %   94.9% 61.9% 60.4% 79.1% 59.1% 84.5% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   31.4% 26.7% 26.1% 33.9% 31.8% 40.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2.3% 89.5% 39.9% 16.4% 3.3% -117.5% 0.0% 0.0%   Gearing %   118.5% 96.1% 81.5% 53.4% 56.3% 31.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.2% 2.7% 1.7% 1.9% 0.9% 6.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 0.2 0.3 0.5 0.5 1.1 0.0 0.0   Current Ratio   1.7 0.5 0.6 0.8 0.7 1.3 0.0 0.0   Cash and cash equivalent   1,522.1 194.8 580.2 890.5 1,255.5 8,137.9 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   859.9 -1,259.1 -1,376.0 -697.9 -1,054.6 1,943.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   216 103 131 139 102 214 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   216 103 131 139 94 214 0 0   EBIT / employee   193 84 80 108 76 181 0 0   Net earnings / employee   148 63 62 84 60 138 0 0